Disease-modifying effects on chronic axon damage and white matter degeneration with 4-aminopyridine after acute traumatic brain injury

Kryslaine L. Radomski, Xiaomei Zi, Genevieve M. Sullivan, Regina C. Armstrong · 2026

Read Disease-modifying effects on chronic axon damage and white matter degeneration with 4-aminopyridine after acute traumatic brain injury by Kryslaine L. Radomski, Xiaomei Zi, Genevieve M. Sullivan, Regina C. Armstrong (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/PMC13427476.txt.

Description

Kryslaine L. Radomski, Xiaomei Zi, Genevieve M. Sullivan, and Regina C. Armstrong tested a multiple sclerosis drug against chronic axon damage after brain injury in a 2026 mouse study. Traumatic injury tears axons and unravels their insulation, driving long-term white matter degeneration, and no therapy effectively treats damaged axons. The team targeted early reversible changes at nodes of Ranvier where potassium channels become exposed by demyelination.

Adult mice of both sexes received a low, clinically relevant dose of 4-aminopyridine, at 0.5 milligrams per kilogram twice daily starting one day after injury for four weeks, or saline. Early channel blockade is tested as a disease-modifying strategy beyond its approved symptom role.

Catalog record

CREATORKryslaine L. Radomski, Xiaomei Zi, Genevieve M. Sullivan, Regina C. Armstrong
YEAR2026
COLLECTIONPAPERS
FORMATTXT
FILE SIZE45066
LICENSEhttps://creativecommons.org/licenses/by/4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/article/MED/PMC13427476

Browse the full library · About the Tower of Babel